Source file signed link, expires in 15 minutes
Extracted text 33
Page 1
PAPARAN PUBLIK
Public Expose
PT Darya-Varia Laboratoria Tbk
Jakarta, 11 June 2024
Page 2
TOPIK
Topics
01
Tinjauan Pasar
Market Overview
02
Sekilas Darya-Varia
Darya-Varia at a Glance
03
Tinjauan Bisnis
Business Overview
Page 3
TINJAUAN PASAR MARKET OVERVIEW
Page 4
TINJAUAN PASAR
Market Overview
SUKU BUNGA TINGGI
Pertumbuhan 2023 High Interest Rates
2023 Growth
PDB/ GDP: 5,05%
Industri Farmasi/ PERGESERAN PREFERENSI
Pharma Industry: KONSUMEN DI PASAR OBAT BEBAS
-0,1% Shift in consumer preferences toward
OTC markets
OBAT BEBAS
OTC
-7% PENJUALAN IMMUNOBOOSTER
DAN MULTIVITAMIN
Sales of immunobooster and multivitamin
OBAT RESEP
PRESCRIPTION
-
+4%
KASUS CEMARAN ED-DEG
EG-DEG contaminations
Di tahun 2023, Indonesia mencatat pertumbuhan di atas rata-rata sebesar 5,05%, akan tetapi, industri farmasi
masih menghadapi hambatan yang signifikan, melambat 0,1%
In 2023, as Indonesia recorded a higher-than-average 5.05% growth, the pharmaceutical industry continued to face significant
headwinds, slowed down to 0.1%
Page 5
SEKILAS DARYA-VARIA Darya-Varia at a Glance
Page 6
SEKILAS DARYA-VARIA
Darya-Varia at a Glance
Visi Vision
Menjadi perusahaan terbaik
yang menyediakan solusi
kesehatan berkualitas di Misi Mission
Indonesia
We shall be the best provider of
Kami membangun Indonesia
quality health and wellness yang lebih sehat setiap orang di
solutions in Indonesia setiap waktu melalui produk
dan pelayanan unggulan,
bekerja sama sebagai satu
keluarga “BERSATU”
We build a healthier Indonesia one
person at a time with market leading
products and services, working -
together as one “BERSATU” family
Page 7
SEKILAS DARYA-VARIA
Darya-Varia at a Glance
Bisnis
Obat Resep
Prescription Vietnam
Business Philippines
Malaysia
Indonesia
Bisnis
Consumer
Health Bisnis Konsultasi
Consumer Bisnis Ekspor & Manajemen
Health
Toll Manufacturing Management
Business Consultancy Business
Toll Manufacturing
& Export Business
Page 8
SEKILAS DARYA-VARIA
Darya-Varia at a Glance
Trusted partner in
Toll Manufacturing & Export
Business Partners Markets
Collaborate with
local & multinational companies
Indonesia The Philippines Services:
▪ R&D
▪ Technical know-how
▪ Product trials
▪ Stability studies
▪ Regulatory consult
▪ Sourcing materials
Vietnam Myanmar ▪ Project management
-
Malaysia Mongolia
Singapore
Page 9
TONGGAK SEJARAH Milestone
Page 10
SEKILAS DARYA-VARIA
Darya-Varia at a Glance
Gunung Putri Plant Citeureup Plant
Page 11
TINJAUAN BISNIS Business Overview
Page 12
TINJAUAN BISNIS 2023
2023 Business Overview
Pendapatan Perseroan mengalami kontraksi sebesar 1% pada tahun 2023 menjadi Rp1,89 triliun -
Bisnis obat resep tumbuh 11%
The Company’s revenues contracted by 1% in 2023 to Rp1.89 trillion – Prescription business grew by 11%
Toll Manufacturing & Konsultasi Manajemen |
Exports Business Management Consultancy
Rp 194 M Rp 27 M
12%
Disdurin Ped
2023
Pendapatan/
Revenue: Manager
Bisnis Obat Resep | Rp1,89 T
Prescription Business Bisnis Consumer Health |
Consumer Health Business
-
11% Rp 708 M 9% Rp 962 M
Page 13
BISNIS CONSUMER HEALTH 2023
2023 Consumer Health Business
Pascapandemi, konsumsi multivitamin bukan lagi
menjadi prioritas kebutuhan sehari-hari
Post-pandemic, consumers no longer prioritized
multivitamin consumption as part of their daily needs
-
Page 14
BISNIS CONSUMER HEALTH 2023
2023 Consumer Health Business
Kami terus berinvestasi secara signifikan dalam branding dan pemasaran produk-produk utama
We continued to make significant investments in our flagship products’ branding and marketing
Brand Campaigns to Drive Relevance Launch of New Products
Page 15
BISNIS CONSUMER HEALTH 2023
2023 Consumer Health Business
66% 77% 18% 28% 34% 36%
+6 pts +4 pts +1 pt +1 pt +1 pt +2 pts
Value Share Units Share Value Share Units Share Value Share Units Share
Natur-E menjaga kepemimpinan Enervon menjaga kepemimpinannya Vicee terus menjadi pesaing kuat di
pasarnya dan meraih pangsa pasar dalam hal unit di segmen Vitamin kategorinya dan memperoleh pangsa pasar
secara signifikan di 2023 Daya Tahan Tubuh dan meraih pangsa di kategori Vitamin C Sweetlets
pasar di 2023
Natur-E maintains dominant leadership and Vicee remained a formidable contender in its
significantly gained market shares in 2023 Enervon maintained leadership in unit category and gained market share in the
shares in Body Resistance Vitamins market Vitamin C Sweetlets category
-
and gained share in 2023
*) Source: AC Nielsen Retail Audit FY2023
Page 16
BISNIS CONSUMER HEALTH 2023
2023 Consumer Health Business
Pendapatan (Rp Milyar) Pertumbuhan
Revenue (Rp Billion) Growth Produk Baru 2023 – Consumer Health
2023 New Products - Consumer Health
962 -9%
Page 17
BISNIS OBAT RESEP 2023
2023 Prescription Business
Pendapatan (Rp Milyar) Pertumbuhan
Revenue (Rp Billion) Growth
708 +11%
Produk Baru 2023 – Obat Resep
2023 New Products - Prescription
Page 18
BISNIS TOLL MANUFACTURING & EKSPOR 2023
2023 Toll Manufacturing & Export Business
Pendapatan (Rp Milyar) Pertumbuhan
Revenue (Rp Billion) Growth
194 -12%
Page 19
TINJAUAN BISNIS
Business Overview
Q4 2022- Q4 2023 Q3 - Q4 2023
47 % 39 %
Penjualan Perseroan tumbuh 47% pada Q4 2023, lebih
tinggi 39% dibandingkan Q4 2022
The Company’s net sales grew by 47% in the final quarter of
2023, which is 39% greater than in the final quarter’s of 2022
Page 20
TINJAUAN BISNIS
Business Overview
Bisnis Consumer Health Perseroan tumbuh 17% pada Kuartal 1 2024
Consumer Health business grew by 17% in Quarter 1 2024
252
215
Bisnis
Consumer
Health
Consumer
Health
Business
2023 2024
Total Pendapatan CH Q1 2023 vs Q1 2024
CH Total Revenues Q1 2023 vs Q1 2024
*) Miliar Rupiah | Billion Rupiah
Page 21
BISNIS CONSUMER HEALTH KUARTAL 1 2024
2024 Q1 Consumer Health Business
Program Marketing dan Branding 2024
Page 22
TINJAUAN BISNIS KUARTAL 1 2024
2024 Q1 Business Overview
Total Pendapatan DVL Kuartal 1 2024 naik 4%, lebih tinggi dari pertumbuhan industri farmasi
DVL’s total revenues in first quarter of 2024 grew by 4%, higher than the pharmaceutical industry growth
532
513
Net Profit :
Revenue
+11%
Growth: +4%
67
61
2023 2024 2023 2024
Total Pendapatan (dalam miliar Rupiah) Laba Bersih (dalam miliar Rupiah)
Total Revenues (in billion Rupiah) Net Profit (in billion Rupiah)
Page 23
PROGRAM KAMPUS BERSATU
Kampus BERSATU Program
Launching Ceremony General Learning Program
CADET Program
Learning Festival LinkedIn Learning Kickoff
Page 24
PROPOSISI NILAI KARYAWAN Employee Value Proposition (EVP)
Page 25
TINJAUAN BISNIS Business Overview
Page 26
TINJAUAN BISNIS Business Overview
Page 27
TINJAUAN BISNIS
Business Overview
Kinerja tata kelola Perusahaan di 2023 termasuk perumusan kebijakan baru untuk mematuhi Undang-Undang Pelindungan
Data Pribadi, pernyataan komitmen anti-monopoli, dan pembentukan Komite Eksekutif di bawah Direksi sebagai wujud
pendekatan yang holistik dalam pengelolaan dan pengambilan keputusan di Perseroan.
The Corporate governance programs in 2023 including formulating new policies to comply with the Personal Data Protection Law, formalized
our commitment to anti-monopoly, and established a new committee under the Board of Directors, the Executive Committee, embodying our
holistic approach to corporate management and decision-making.
Personal Data Anti Monopoly Executive
Protection Compliance Committee
Page 28
PILAR KEBERLANJUTAN DARYA-VARIA
Darya-Varia’s Sustainability House
Mengelola Dampak
Meningkatkan Kesehatan,
01 Kesejahteraan & Kualitas Hidup
Improving Health, Well-Being &
03 Lingkungan Kita
Managing Our
Quality of Lives Environmental Impacts
Membangun Perusahaan yang Tata Kelola yang Tegas untuk
02 Mengutamakan Karyawan
Building a Company
04 Bisnis yang Bertanggung Jawab
& Etis
Of People Firm Governance for Responsible &
Ethical Business
-
Page 29
TINJAUAN BISNIS
Business Overview
Target Keberlanjutan 2030 : mengurangi emisi gas rumah kaca sebesar 30%, penggunaan air sebesar
30%, dan total limbah sebesar 30%, serta mencapai status zero landfill
Sustainability Targets for 2030 : reducing greenhouse gas emissions by 30%, water usage by 30%, total waste by
30%, as well as attaining zero landfill status
Page 30
LAPORAN TAHUNAN TERINTEGRASI 2023
2023 Integrated Annual Report
Laporan Tahunan 2023
Tersedia di website kami: www.darya-varia.com
2024 Annual Report
Available in our website: www.darya-varia.com
Page 31
PAPARAN PUBLIK 2024 2024 Public Expose
Page 32
SESI TANYA JAWAB Q&A Session
Page 33
PT DARYA-VARIA LABORATORIA Tbk
SOUTH QUARTER TOWER C
18TH - 19TH FLOOR
JL. R.A. KARTINI KAV. 8
JAKARTA 12430
INDONESIA
1
Names mentioned 1 people and organisations named in the text · linked when the evidence is strong
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
No extraction attempted yet.